✦ LIBER ✦

Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation

✍ Scribed by van der Houwen, Lisette E.E.; Mijatovic, Velja; Leemhuis, Elmer; Schats, Roel; Heymans, Martijn W.; Lambalk, Cornelis B.; Hompes, Peter G.A.

Book ID: 121473065
Publisher: Reproductive Healthcare Ltd
Year: 2014
Tongue: English
Weight: 604 KB
Volume: 28
Category: Article
ISSN: 1472-6491
DOI: 10.1016/j.rbmo.2013.09.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adenomyosis has no adverse effects on IV

Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI

✍ V. Mijatovic; E. Florijn; N. Halim; R. Schats; P. Hompes 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Long-Term Efficacy and Safety of Rosuvas

Long-Term Efficacy and Safety of Rosuvastatin 40 mg in Patients With Severe Hypercholesterolemia

✍ Evan A. Stein; John Amerena; Christie M. Ballantyne; Edmund Brice; Michel Farnie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Long-term efficacy and safety of etanerc

Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis

✍ Brandt, J. 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 132 KB

Long-term safety and efficacy of adalimu

Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease

✍ Watanabe, Mamoru; Hibi, Toshifumi; Mostafa, Nael M.; Chao, Jingdong; Arora, Vipi 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 945 KB

Long term efficacy, safety, and tolerabi

Long term efficacy, safety, and tolerability of candesartan cilexetil added to hydrochlorothiazide in patients with severe systemic hypertension

✍ Suzanne Oparil; EricL. Michelson 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB

226 EFFICACY AND SAFETY OF SORAFENIB AT

226 EFFICACY AND SAFETY OF SORAFENIB AT LONG TERM IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): NEED TO SCREEN FOR CARDIOVASCULAR EVENTS AFTER LONG TERM ADMINISTRATION

✍ M. Reig; A. Forner; C. Rodriguez de Lope; J. Rimola; S. Tremosini; C. Mestres; C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB